1. FRI0228 Ugt1a1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab. (15th June 2017) Authors: Damask, A; Boyapati, A; Hamilton, JD; Hamon, S; Paccard, C; Parrino, J; Adelsberg, J van; Graham, NM; Penn, J; Lopez, A; Reid, J; Overton, J; Baras, A; Shuldiner, AR; Paulding, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis. (15th June 2017) Authors: Strand, V; Gossec, L; Proudfoot, C; Chen, C; Reaney, M; Guillonneau, S; Kimura, T; Adelsberg, J van; Lin, Y; Mangan, E; Hoogstraten, H van; Burmester, GR Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0179 The ASP358ALA variant in the IL6R gene is significantly associated with differences in soluble IL-6R protein levels but not with differences in sarilumab response in rheumatoid arthritis (RA) patients. (15th June 2017) Authors: Damask, A; Boyapati, A; Hamilton, JD; Hamon, S; Paccard, C; Parrino, J; Adelsberg, J van; Graham, NM; Penn, J; Lopez, A; Reid, J; Overton, J; Baras, A; Shuldiner, AR; Paulding, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗